Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1186-1188

  Shortridge, Virginia D ^a,c   Doern, Gary V ^b   Brueggemann, Angela B ^b   Beyer, Jill M ^a   Flamm, Robert K ^a  

^a ABBOTT LABORATORIES   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c Building AP52N ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNITED STATES;

ANTI-BACTERIAL AGENTS; DNA-BINDING PROTEINS; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; TRANSCRIPTION FACTORS; UNITED STATES;

EID: 0033512553     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313452     Document Type: Article

References (17)

1. 1. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother 1991;28:31-8.
2. 2. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis 1998;27:764-70.
3. 3. Goldstem FW, Garau J. Resistant pneumococci: a renewal threat in respiratory infections. Scand J Infect Dis Suppl 1994;93:55-62.
4. 4. Doit C, Denamur E, Picard B, Geslin P, Elion J, Bingen E. Mechanisms of the spread of penicillin resistance in Streptococcus pneumoniae strains causing meningitis in children in France. J Infect Dis 1996; 174:520-8.
5. 5. Arthur M, Brisson-Noel A, Courvalin P. Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypothesis. J Antimicrob Chemother 1987;20:783-802.
6. 6. Mayford M, Weisblum B. Conformational alterations in the ermC transcript in vivo during induction. EMBO J 1989;8:4307-14.
7. 7. Seppala H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993;32:885-91.
8. 8. Shortridge VD, Flamm RK, Ramer N, Beyer J, Tanaka SK. Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn Microbiol Infect Dis 1996;26:73-8.
9. 9. Tait-Kamradt A, Clancy J, Cronan M, et al. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997;41:2251-5.
10. 10. Clancy J, Petitpas J, Dib-Hajj F, et al. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol Microbiol 1996;22:867-79.
11. 11. Shortridge D, Ramer N, Darwish A, Flamm RK. Activity of the ketolide ABT-773 as measured by broth microdilution against macrolide-susceptible and macrolide-resistant Streptococcus spp [abstract no. P178]. Clin Microbiol Infect 1999;5(Suppl 3):132.
12. 12. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother 1996; 40:1208-13.
13. 13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 8th ed. NCCLS document M7-A4. Villanova, Pennsylvania: National Committee for Clinical Laboratory Standards, 1998.
14. 14. Sanchez ML, Flint KK, Jones RN. Occurrence of macrolide-lincosamide-streptogramin resistances among staphylococcal clinical isolates at a university medical center: is false susceptibility to new macrolides and clindamycin a contemporary clinical and in vitro testing problem? Diagn Microbiol Infect Dis 1993; 16:205-13.
15. 15. Johnston NJ, Azavedo JCD, Kellner JD, Low DE. Prevalence and characterization of the mechanisms of macrolide, lincosamide and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998;42:2425-6.
16. 16. Gay K, Miller Y, Jackson D, Farley M, Tenover F, Stephens D. Population-based assessment of the mechanisms of high-level erythromycin resistance in Streptococcus pneumoniae [abstract no. C-33]. In: Program and abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 1998.
17. 17. Patel KB, Xuan D, Tessier PR, Russomanno JH, Quintiliani R, Nightingale CH. Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. Antimicrob Agents Chemother 1996;40:2375-9.